|
⚲
|
| Keyboard |
| Dunlop A Sinclair
✚
|
|
|---|---|
| CIK # | 0001721108 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001721108] | |
| 4 | [0001721108] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Dunlop A Sinclair | |
| Apellis Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-01 | Grant | 7,961 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 14,684 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-10-10 | Other | 3,837 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-10-10 | Sell | 31,092 | $23.72 | 737,502 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-09-30 | Other | 3,837 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-09-30 | Sell | 31,092 | $22.58 | 702,057 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-06-24 | Other | 4,787 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-01 | Grant | 6,267 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-01-01 | Grant | 11,199 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-09-23 | Option exercise | 4,600 | $13.19 | 60,674 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-09-23 | Option exercise | 4,600 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-09-16 | Sell | 29,476 | $36.09 | 1,063,789 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-09-16 | Sell | 7,524 | $36.79 | 276,808 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-06-28 | Option exercise | 900 | $13.19 | 11,871 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-06-28 | Option exercise | 900 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-06-21 | Sell | 1,695 | $39.63 | 67,173 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-06-21 | Sell | 35,305 | $39.22 | 1,384,662 |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-04-12 | Option exercise | 1,500 | $13.19 | 19,785 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-04-12 | Option exercise | 1,500 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-03-19 | Sell | 18,681 | $57.18 | 1,068,180 |
| showing 20 of 87 most recent transactions | |||||